Skip to content

To evaluate that catheter ablation of atrial fibrillation decrease serum uric acid level

To evaluate that catheter ablation of atrial fibrillation decrease serum uric acid level - Study of association between AF ablation and uric acid level

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000044669
Enrollment
210
Registered
2021-06-28
Start date
2021-06-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

None listed

Sponsors

University of Fukui
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: AF patients who underwent initial AF ablation in our hospital between was included.

Exclusion criteria

Exclusion criteria: Patients with exchanging oral medicines for heart failure, hypertension, diabetes mellitus, dyslipidemia, and hyperuricemia drug during follow-up period, and those with receiving dialysis were excluded.

Design outcomes

Primary

MeasureTime frame
Biomarkers of uric acid (UA), sugar and lipid metabolism after catheter ablation

Countries

Japan

Contacts

Public ContactDaisetsu Aoyama

University of Fukui Department of Cardiovascular Medicine, Faculty of Medical Sciences

daisetsu@u-fukui.ac.jp0776618800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026